Dermata Therapeutics, Inc. (DRMA) SEC filings
DRMA SEC filings moved a median of -1.18% by the close. DRMA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DRMA overview →
97 measured DRMA SEC filing events.
Where these DRMA SEC filings landedvs 97 measured DRMA SEC filing reactions
| Middle 50% of DRMA SEC filing reactions | -4.80% to +1.70% |
|---|---|
| Median reaction (to close) | -1.18% |
| Measured reactions | 97 |
Point-in-time · zero look-ahead
Half of the 97 DRMA SEC filing events with a measured close landed between -4.80% and +1.70%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | — | -12.78% | |
| Form 8-K Dermata Therapeutics, For: Aug 16 | SEC filing · Form 8-K | -2.41% | +0.69% | |
| Form 10-Q Dermata Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.20% | +10.40% | |
| Form 8-K Dermata Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -1.20% | +10.40% | |
| Form 8-K Dermata Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +0.34% | +3.54% | |
| Form S-8 Dermata Therapeutics, | SEC filing · Form S-8 | +0.01% | -5.60% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | -3.03% | +1.51% | |
| Form 8-K Dermata Therapeutics, For: May 27 | SEC filing · Form 8-K | +3.20% | +8.00% | |
| Form S-3/A Dermata Therapeutics, | SEC filing · Form S-3 | +0.00% | -3.91% | |
| Form 10-Q Dermata Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.81% | +0.00% | |
| Form 8-K Dermata Therapeutics, For: Mar 31 | SEC filing · Form 8-K | -0.81% | +0.00% | |
| Form DEF 14A Dermata Therapeutics, For: Apr 17 | SEC filing · Form DEF | -0.36% | -4.35% | |
| Form ARS Dermata Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.74% | -0.74% | |
| Form DEF 14A Dermata Therapeutics, For: Apr 17 | SEC filing · Form DEF | +0.74% | -0.74% | |
| Form DEFA14A Dermata Therapeutics, | SEC filing · Form DEFA14A | +0.74% | -0.74% | |
| Form PRE 14A Dermata Therapeutics, For: Apr 06 | SEC filing · Form PRE | -0.79% | +3.70% | |
| Form 10-K Dermata Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.21% | -13.23% | |
| Form 8-K Dermata Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -2.21% | -13.23% | |
| Form 8-K Dermata Therapeutics, For: Feb 23 | SEC filing · Form 8-K | +2.63% | +2.46% | |
| Form 8-K Dermata Therapeutics, For: Jan 30 | SEC filing · Form 8-K | +3.48% | +3.21% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | +0.90% | -19.36% | |
| Form 8-K Dermata Therapeutics, For: Jan 27 | SEC filing · Form 8-K | +1.06% | -8.51% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | +1.63% | -8.05% | |
| Form D Dermata Therapeutics, | SEC filing · Form D | +0.46% | -2.73% | |
| Form 8-K Dermata Therapeutics, For: Dec 23 | SEC filing · Form 8-K | +1.65% | -5.79% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | -1.46% | +8.03% | |
| Form 8-K Dermata Therapeutics, For: Nov 17 | SEC filing · Form 8-K | -2.18% | -2.91% | |
| Form 10-Q Dermata Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -7.03% | -9.27% | |
| Form 8-K Dermata Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -7.03% | -9.27% | |
| Form 8-K Dermata Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -1.00% | +7.47% | |
| Form 8-K Dermata Therapeutics, For: Sep 17 | SEC filing · Form 8-K | -2.03% | -5.42% | |
| Form 8-K Dermata Therapeutics, For: Sep 10 | SEC filing · Form 8-K | -1.82% | +0.00% | |
| Form 8-K Dermata Therapeutics, For: Aug 22 | SEC filing · Form 8-K | — | -4.51% | |
| Form 10-Q Dermata Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.68% | -7.04% | |
| Form 8-K Dermata Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +1.68% | -7.04% | |
| Form 8-K Dermata Therapeutics, For: Jul 30 | SEC filing · Form 8-K | — | -4.37% | |
| Form 8-K Dermata Therapeutics, For: Jul 15 | SEC filing · Form 8-K | -1.35% | -2.64% | |
| Form 8-K Dermata Therapeutics, For: Jul 02 | SEC filing · Form 8-K | -6.74% | -7.04% | |
| Form 8-K Dermata Therapeutics, For: Jun 03 | SEC filing · Form 8-K | +0.00% | +7.67% | |
| Form ARS Dermata Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | -1.18% | |
| Form DEF 14A Dermata Therapeutics, For: Jun 02 | SEC filing · Form DEF | — | -1.18% | |
| Form DEFA14A Dermata Therapeutics, | SEC filing · Form DEFA14A | — | -1.18% | |
| Form PRE 14A Dermata Therapeutics, For: May 23 | SEC filing · Form PRE | +0.00% | -1.32% | |
| Form 8-K Dermata Therapeutics, For: May 20 | SEC filing · Form 8-K | +0.00% | -6.07% | |
| Form 8-K Dermata Therapeutics, For: May 14 | SEC filing · Form 8-K | — | +9.07% | |
| Form 10-Q Dermata Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.01% | -0.97% | |
| Form 8-K Dermata Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.01% | -0.97% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | -2.26% | -4.80% | |
| Form 8-K Dermata Therapeutics, For: Apr 15 | SEC filing · Form 8-K | -1.34% | -9.43% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | +0.00% | -2.47% | |
| Form 8-K Dermata Therapeutics, For: Mar 27 | SEC filing · Form 8-K | +0.92% | -0.92% | |
| Form 8-K Dermata Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -4.25% | -36.04% | |
| Form 8-K Dermata Therapeutics, For: Mar 25 | SEC filing · Form 8-K | +2.94% | -0.73% | |
| Form 10-K Dermata Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.51% | +1.70% | |
| Form 8-K Dermata Therapeutics, For: Mar 17 | SEC filing · Form 8-K | -0.51% | +1.70% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | -1.60% | -2.40% | |
| Form D/A Dermata Therapeutics, | SEC filing · Form D | -1.48% | -0.78% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | +0.00% | +1.65% | |
| Form D Dermata Therapeutics, | SEC filing · Form D | -0.66% | +0.00% | |
| Form 8-K Dermata Therapeutics, For: Jan 21 | SEC filing · Form 8-K | -0.83% | -3.31% | |
| Form 8-K Dermata Therapeutics, For: Jan 17 | SEC filing · Form 8-K | -1.52% | +0.79% | |
| Form 8-K Dermata Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +0.00% | -3.33% | |
| Form 10-Q Dermata Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.33% | |
| Form D Dermata Therapeutics, | SEC filing · Form D | +0.00% | +3.15% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | +2.67% | +3.33% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | +2.81% | +0.00% | |
| Form 8-K Dermata Therapeutics, For: Sep 16 | SEC filing · Form 8-K | +5.70% | +16.58% | |
| Form 10-Q Dermata Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.33% | +21.86% | |
| Form 8-K Dermata Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +2.33% | +21.86% | |
| Form S-8 Dermata Therapeutics, | SEC filing · Form S-8 | +2.33% | +21.86% | |
| Form 8-K Dermata Therapeutics, For: Aug 02 | SEC filing · Form 8-K | -3.85% | -8.04% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | -3.04% | -4.78% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | +3.62% | +3.51% | |
| Form 8-K Dermata Therapeutics, For: Jun 07 | SEC filing · Form 8-K | — | -12.00% | |
| Form 8-K Dermata Therapeutics, For: Jun 04 | SEC filing · Form 8-K | +0.00% | +0.78% | |
| Form 8-K Dermata Therapeutics, For: May 20 | SEC filing · Form 8-K | — | -3.82% | |
| Form 8-K Dermata Therapeutics, For: May 17 | SEC filing · Form 8-K | +0.23% | -14.74% | |
| Form 10-Q Dermata Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +9.91% | +12.07% | |
| Form 8-K Dermata Therapeutics, For: May 14 | SEC filing · Form 8-K | -0.15% | -2.22% | |
| Form 8-K Dermata Therapeutics, For: May 15 | SEC filing · Form 8-K | +9.91% | +12.07% | |
| Form 8-K Dermata Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.03% | -1.58% | |
| Form 8-K Dermata Therapeutics, For: May 07 | SEC filing · Form 8-K | -0.09% | -1.42% | |
| Form ARS Dermata Therapeutics, For: Dec 31 | SEC filing · Form ARS | +3.45% | -0.98% | |
| Form DEF 14A Dermata Therapeutics, For: Mar 05 | SEC filing · Form DEF | +3.45% | -0.98% | |
| Form DEFA14A Dermata Therapeutics, | SEC filing · Form DEFA14A | +3.45% | -0.98% | |
| Form 10-K Dermata Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.15% | -4.55% | |
| Form 8-K Dermata Therapeutics, For: Mar 21 | SEC filing · Form 8-K | -1.15% | -4.55% | |
| Form PRE 14A Dermata Therapeutics, For: Feb 28 | SEC filing · Form PRE | -1.78% | -2.14% | |
| Form 8-K Dermata Therapeutics, For: Jan 12 | SEC filing · Form 8-K | +0.58% | -11.77% | |
| Form EFFECT Dermata Therapeutics, | SEC filing · Form EFFECT | +0.00% | -7.14% | |
| Form DEF 14A Dermata Therapeutics, For: Dec 07 | SEC filing · Form DEF | +0.00% | -7.89% | |
| Form S-3 Dermata Therapeutics, | SEC filing · Form S-3 | — | +2.29% | |
| Form PRE 14A Dermata Therapeutics, For: Nov 28 | SEC filing · Form PRE | -2.06% | +2.86% | |
| Form 8-K Dermata Therapeutics, For: Nov 16 | SEC filing · Form 8-K | -2.82% | +24.56% | |
| Form 8-K Dermata Therapeutics, For: Nov 15 | SEC filing · Form 8-K | +8.12% | -9.64% | |
| Form 10-Q Dermata Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.00% | -3.02% | |
| Form 8-K Dermata Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -2.00% | -3.02% |
Keep exploring
More DRMA: earnings → · analyst actions → · DRMA overview →